Pliant Therapeutics, Inc.
NASDAQ:PLRX
15.19 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 63.234 | 33.685 | 51.665 | 50.882 | 85.807 | 60.949 | 4.251 |
| Short Term Investments
| 431.011 | 297.502 | 148.931 | 226.012 | 16.966 | 0 | 0 |
| Cash and Short Term Investments
| 494.245 | 331.187 | 200.596 | 276.894 | 102.773 | 60.949 | 4.251 |
| Net Receivables
| 2.997 | 2.066 | 2.081 | 9.362 | 7.385 | 0.5 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 8.26 | 7.058 | 6.764 | 4.498 | 1.742 | 0.284 | 0.456 |
| Total Current Assets
| 505.502 | 340.311 | 209.441 | 290.754 | 111.9 | 61.733 | 4.707 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 4.778 | 9.908 | 10.936 | 4.321 | 4.079 | 4.26 | 1.846 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 1.482 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.392 | 0.394 | 0.838 | 0.451 | 3.085 | 0.536 | 0 |
| Total Non-Current Assets
| 6.652 | 10.302 | 11.774 | 4.772 | 7.164 | 4.796 | 1.846 |
| Total Assets
| 512.154 | 350.613 | 221.215 | 295.526 | 119.064 | 66.529 | 6.553 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 4.531 | 1.58 | 2.971 | 2.023 | 1.25 | 2.576 | 1.594 |
| Short Term Debt
| 1.318 | 2.457 | 1.869 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 22.675 | 19.876 | 11.991 | 9.576 | 6.922 | 2.508 | 1.594 |
| Total Current Liabilities
| 28.524 | 23.913 | 16.831 | 11.599 | 8.172 | 5.084 | 3.188 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 10.054 | 13.358 | 5.325 | 0.283 | 0.444 | 0.525 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0.583 | 110.883 | 61.802 | 0 |
| Total Non-Current Liabilities
| 10.054 | 13.358 | 5.325 | 0.866 | 111.327 | 62.327 | 0 |
| Total Liabilities
| 38.578 | 37.271 | 22.156 | 12.465 | 119.499 | 67.411 | 3.188 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 295.526 | 75.86 | 70.587 | 39.91 |
| Common Stock
| 0.006 | 0.005 | 0.003 | 0.003 | 0.001 | 0.001 | 0.001 |
| Retained Earnings
| -499.748 | -338.412 | -215.091 | -117.828 | -76.295 | -71.47 | -36.566 |
| Accumulated Other Comprehensive Income/Loss
| 0.345 | -1.958 | -0.201 | -0.032 | -0.001 | -1.075 | 0 |
| Other Total Stockholders Equity
| 972.973 | 653.707 | 414.348 | 105.392 | 0 | 1.075 | -0 |
| Total Shareholders Equity
| 473.576 | 313.342 | 199.059 | 283.061 | -0.435 | -0.882 | 3.345 |
| Total Equity
| 473.576 | 313.342 | 199.059 | 283.061 | -0.435 | -0.882 | 3.345 |
| Total Liabilities & Shareholders Equity
| 512.154 | 350.613 | 221.215 | 295.526 | 119.064 | 66.529 | 6.533 |